Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V97.7.2053PMID 11264171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.

  2000cited by this paper
• Plasma TAFI Antigen Variations in Healthy Subjects

  2000cited by this paper
• Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.

  2000cited by this paper
• Thrombin-Activatable Fibrinolysis Inhibitor Antigen Levels and Cardiovascular Risk Factors

  2000cited by this paper
• Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B).

  1999cited by this paper
• Identification and Characterization of Two Thrombin-activatable Fibrinolysis Inhibitor Isoforms

  1998cited by this paper
• Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.

  1998cited by this paper
• A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor*

  1998cited by this paper
• Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population.

  1997cited by this paper
• On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase B*

  1997cited by this paper
• The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.

  1996cited by this paper
• Plasma carboxypeptidases as regulators of the plasminogen system.

  1995cited by this paper
• Testing for association between disease and linked marker loci: a log-linear-model analysis.

  1991cited by this paper
• Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma.

  1991cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper

• Association of Carboxypeptidase B2 Gene Polymorphisms With Graft Loss in Kidney Transplantation

  2026cites this paper
• Relationship Between Polymorphism of Thrombin-Activatable Fibrinolysis Inhibitor Gene +1040C/T and a Cohort of Chinese Women With Recurrent Spontaneous Abortion

  2021cites this paper
• Identification of genetic risk factors associated with ischaemic stroke in young Mexican patients.

  2019cites this paper
• Genetic Polymorphisms Associated with Thrombotic Disease Comparison of Two Territories: Myocardial Infarction and Ischemic Stroke

  2019cites this paper
• Association of TAFI gene polymorphisms with severity of coronary stenosis in stable coronary artery disease.

  2018cites this paper
• A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor

  2018cites this paper
• Identification of genetic risk factors associated with ischaemic stroke in young Mexican patients.

  2018cites this paper
• The Impact of Ethnicity on Lipoproteins in Coronary Artery Disease

  2017cites this paper
• Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome.

  2017cites this paper
• Changes in thrombin activatable fibrinolysis inhibitor and its role in normal pregnancy and pre-eclampsia

  2017cites this paper
• Impact of Thrombomodulin and Thrombin-Activatable Fibrinolysis Inhibitor on the Anticoagulant and Profibrinolytic Effects of Rivaroxaban

  2016cites this paper
• Gene Variations in the Protein C and Fibrinolytic Pathway: Relevance for Severity and Outcome in Pediatric Sepsis

  2016cites this paper
• Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study

  2015cites this paper
• Thrombin‐activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis

  2015cites this paper
• Effect of single nucleotide polymorphism in thrombin-activatable fibrinolysis inhibitor on the risk of diabetic macrovascular disease

  2015cites this paper
• Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.

  2015cites this paper
• Genetic variations in the thrombin-activatable fibrinolysis inhibitor gene and risk of cardiovascular disease: a systematic review and meta-analysis.

  2014cites this paper
• Inherited risk factors for venous thromboembolism

  2014cites this paper
• The role of coagulation factor XII in fibrin clot formation and fibrinolysis

  2014cites this paper
• Regulation of expression of CPB2, the gene encoding human thrombin activatable fibrinolysis inhibitor (TAFI): the role for post-transcriptional regulation

  2014cites this paper
• Model Systems to Explore CPB2 Pre-mRNA Splicing

  2014influential citation
• Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.

  2014cites this paper
• Thrombin-activatable fibrinolysis inhibitor (TAFI) levels and its polymorphism rs3742264 are associated with dyslipidemia in a cohort of Brazilian subjects.

  2014cites this paper
• Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese population

  2014influential citation
• human platelets Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in

  2013cites this paper
• activatable fibrinolysis inhibitor antigen levels by a trans-ethnic study Fine mapping of quantitative trait nucleotides underlying thrombin

  2013cites this paper
• The mRNA encoding TAFI is alternatively spliced in different cell types and produces intracellular forms of the protein lacking TAFIa activity

  2013cites this paper
• Prevalence of thrombosis-related DNA polymorphisms in a healthy Greek population.

  2012cites this paper
• Fibrinolysis alterations in infertile women during controlled ovarian stimulation: influence of BMI and genetic components.

  2012cites this paper
• Genetic variation in thrombin-activatable fibrinolysis inhibitor is associated with the risk of diabetic nephropathy

  2012cites this paper
• TAFI gene polymorphisms in patients with cerebral venous thrombosis

  2012cites this paper
• Plasma thrombin-activatable fi brinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients

  2011cites this paper
• Thrombin-activatable fibrinolysis inhibitor and bacterial infections

  2011cites this paper
• [Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications].

  2011cites this paper
• Correlation between Inflammation and Fibrinolysis Impairment on Central Obesity: A Study for hsCRP, PAI-1, PAP and TAFI

  2011cites this paper
• Regulation of the Gene Encoding Thrombin-Activable Fibrinolysis Inhibitor in Non-Hepatic Cells

  2011cites this paper
• An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis.

  2011cites this paper
• Factor XI deficiency : a study of clinical, laboratory and molecular modifiers of bleeding phenotype

  2011cites this paper
• Novel Insights into Genetics of Arterial Thrombosis

  2011cites this paper
• Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Are not Associated With Glucose Intolerance and Subclinical Atherosclerosis in Women With Previous Gestational Diabetes

  2011cites this paper
• Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.

  2011cites this paper
• Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transfer.

  2011cites this paper
• Thrombin activatable fibrinolysis inhibitor (TAFI) in blood of patients with colon and breast cancer

  2010cites this paper
• Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke

  2010cites this paper
• Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome.

  2010cites this paper
• Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation

  2010cites this paper
• Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome.

  2010cites this paper
• Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.

  2010cites this paper
• THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI): Relationship to Hemostatic Alteration in Patients with β-Thalassemia

  2010cites this paper
• Association between the Thr325Ile polymorphism of the thrombinactivatable fibrinolysis inhibitor and stroke in the Ludwigshafen Risk and Cardiovascular Health Study

  2010cites this paper
• [Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis].

  2010cites this paper
• Polymorphisms in the CPB2 gene are maintained by balancing selection and result in haplotype-preferential splicing of exon 7.

  2010influential citation
• Etiology and Clinical Outcome of Budd-Chiari Syndrome and Portal Vein Thrombosis

  2010cites this paper
• The role of the fibrinolytic system in arterial and venous thrombosis

  2010cites this paper
• The Role of Thrombin-Activatable Fibrinolysis Inhibitor in the Pathophysiology of Hemostasis

  2010cites this paper
• analysis encoding thrombin-activatable fibrinolysis inhibitor: a functional Effect of single nucleotide polymorphisms on expression of the gene

  2010cites this paper
• Valor pronóstico de la concentración del inhibidor de la fibrinolisis activable por trombina y del polimorfismo C1040T en el infarto agudo de miocardio tratado con fibrinolisis

  2010cites this paper
• The Role of Thrombin-Activatable Fibrinolysis Inhibitor in the Pathophysiology of Hemostasis

  2010cites this paper
• Polymorphic Variation of Genes in the Fibrinolytic System and the Risk of Ovarian Cancer

  2009cites this paper
• Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.

  2009influential citation
• Thrombin activatable fibrinolysis inhibitor and clot lysis time in pregnant patients with antiphospholipid syndrome: relationship with pregnancy outcome and thrombosis.

  2009cites this paper
• Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients

  2009cites this paper
• Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men

  2009cites this paper
• Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss.

  2009cites this paper
• The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study 1

  2009cites this paper
• Detecting Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) and Inactivated TAFIa (TAFIai) in Normal and Hemophilia A Plasmas

  2009cites this paper
• Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis.

  2008cites this paper
• Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome

  2008cites this paper
• Thrombin activatable fibrinolysis inhibitor gene polymorphisms are associated with antigenic levels in the Asian‐Indian population but may not be a risk for stroke

  2008cites this paper
• TAFI antigen level variability in young healthy Asian Indians; first report from Asia.

  2008cites this paper
• Thrombin activatable fibrinolysis inhibitor in preeclmapsia and gestational hypertension throughout the gestation

  2008cites this paper
• Determinants of plasma levels of von Willebrand factor and coagulation factor VIII

  2008cites this paper
• Infectious Diseases in the Pediatric Intensive Care Unit

  2008cites this paper
• A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels

  2008cites this paper
• Factores de la coagulación y de la fibrinolisis relacionados con la cardiopatía isquémica precoz.

  2007influential citation
• Molecular analysis of the human thrombin‐activatable fibrinolysis inhibitor gene promoter

  2007cites this paper
• ASSESSMENT OF THE ROLE OF THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR IN RETINAL VEIN OCCLUSION

  2007cites this paper
• Predictive genetic variants for venous thrombosis: what's new?

  2007cites this paper
• Plasma coagulation factor levels in venous thrombosis.

  2007cites this paper
• CHAPTER 8 – Molecular Basis of Lipoprotein Disorders, Atherogenesis, and Thrombosis

  2007cites this paper
• Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.

  2007cites this paper
• Fibrinolysis, inflammation, and regulation of the plasminogen activating system

  2007cites this paper
• Thrombin Activatable Fibrinolysis Inhibitor Activation Peptide Shows Association With All Major Subtypes of Ischemic Stroke and With TAFI Gene Variation

  2007cites this paper
• Seminal thrombin-activatable fibrinolysis inhibitor: a regulator of liquefaction

  2007cites this paper
• A role for procarboxypepidase U (TAFI) in thrombosis.

  2007cites this paper
• Fibrinolysis and the risk of venous and arterial thrombosis

  2007cites this paper
• Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis

  2007cites this paper
• Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.

  2007cites this paper
• Plasma Levels of Unactivated Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Are Down‐Regulated in Young Adult Women: Analysis of a Normal Japanese Population

  2007cites this paper
• Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasmaTAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD)

  2006cites this paper
• Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.

  2006cites this paper
• Measurement of procarboxypeptidase U (TAFI) in human plasma: a laboratory challenge.

  2006influential citation
• Genetic influence on thrombotic risk markers in the elderly – a Danish twin study

  2006cites this paper
• Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study.

  2006cites this paper
• TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit.

  2006cites this paper
• Genetics of Coagulation: Considerations for Cardiac Surgery

  2006cites this paper
• The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI‐antigen levels, clot lysis time and the risk of venous thrombosis

  2006influential citation
• ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation

  2006cites this paper
• Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems

  2006cites this paper
• A Locus on Chromosome 13 Influences Levels of TAFI Antigen in Healthy Mexican Americans

  2006cites this paper